SALL4 Gene Expression in Acute Myeloid Leukemia

Area of Science:

• Hematology
• Molecular Biology
• Oncology

Background:

• Aberrant SALL4 gene expression is observed in various leukemia cell lines and primary leukemia cells.
• SALL4's role in self-renewal properties links embryonic stem cells (ESCs), normal hematopoietic stem cells (HSCs), and leukemia stem cells (LSCs).

Purpose of the Study:

• To investigate the expression pattern of the SALL4 gene in adult patients diagnosed with acute myeloid leukemia (AML).
• To evaluate the potential of SALL4 gene expression as a diagnostic and prognostic marker in AML.

Main Methods:

• Quantitative Real-time PCR was employed to measure SALL4 gene expression levels.
• The study included 52 adult Egyptian AML patients and 10 healthy controls.
• Samples were collected from peripheral blood.

Main Results:

• SALL4 gene expression was significantly elevated in AML patients compared to healthy controls (p <0.001).
• None of the control subjects exhibited SALL4 expression above 1.0 RQ, while all AML cases showed higher levels.

Conclusions:

• SALL4 gene expression is a highly sensitive indicator in acute myeloid leukemia.
• SALL4 may function as a predictive marker for prognosis and aid in risk stratification for AML patients.
• Further research with larger patient cohorts is recommended to fully elucidate the prognostic impact of SALL4.